Arcus Biosciences, Inc. SEC filings RCUS
Arcus Biosciences, Inc. has 609 filings in SEC EDGAR's recent list, going back to Dec 15, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 11, 2026 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 10, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | — |
| DEFA14A | Additional proxy material | Apr 20, 2022 | — |
| DEF 14A | Proxy statement | Apr 20, 2022 | Jun 14, 2022 |
| DEFA14A | Additional proxy material | Apr 20, 2021 | — |
| DEF 14A | Proxy statement | Apr 20, 2021 | Jun 3, 2021 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | May 28, 2019 | — |
| DEFA14A | Additional proxy material | Apr 22, 2019 | — |
| DEF 14A | Proxy statement | Apr 22, 2019 | Jun 6, 2019 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RCUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hayward, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1724521
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.